ORTHOPEDIATRICS CORP — Form 10-Q
Filed August 5, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 2/100
What the filing says
David R. Bailey (CEO) and Fred L. Hite (CFO/COO) executed standard Sarbanes-Oxley Sections 302 and 906 certifications on August 5, 2026, for the quarterly period ended June 30, 2026. Both officers certify that the 10-Q contains no material misstatements, fairly presents financial condition and results of operations, and that disclosure controls and internal control over financial reporting are effective. No material weaknesses, deficiencies, or fraudulent activities are disclosed.
Why this rating
Routine periodic certification required by SOX; no operational changes, financial restatements, control failures, or material events disclosed.
See more from August 5, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.